Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 44 publications
Unmet needs in cervical cancer - can biological therapies plug the gap?
Journal: Expert opinion on biological therapy
Published: September 23, 2024
Preclinical activity of datopotamab deruxtecan, a novel TROP2 directed antibody-drug conjugate targeting trophoblast cell-surface antigen 2 (TROP2) in ovarian carcinoma.
Journal: Gynecologic oncology
Published: April 30, 2024
Entering the golden age for antibody-drug conjugates in gynecologic cancer.
Journal: Oncoscience
Published: April 29, 2024
Integrated mutational landscape analysis of poorly differentiated high-grade neuroendocrine carcinoma of the uterine cervix.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: April 16, 2024
Targeting cervical cancer with anti-PD-1 antibodies: what is new?
Journal: Expert opinion on biological therapy
Published: February 23, 2024
Preclinical in vitro and in vivo activity of the RAF/MEK clamp avutometinib in combination with FAK inhibition in uterine carcinosarcomas.
Journal: Gynecologic oncology
Published: February 19, 2024
Trastuzumab deruxtecan (DS-8201a), a HER2-targeting antibody-drug conjugate, demonstrates in vitro and in vivo antitumor activity against primary and metastatic ovarian tumors overexpressing HER2.
Journal: Clinical & experimental metastasis
Published: February 09, 2024
Randomized Phase II Trial of Imiquimod with or without 9-Valent HPV Vaccine versus Observation in Patients with High-grade Pre-neoplastic Cervical Lesions (NCT02864147).
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: November 21, 2023
Antibody-Drug Conjugates (ADC) in HER2/neu-Positive Gynecologic Tumors.
Journal: Molecules (Basel, Switzerland)
Published: September 13, 2023
HER2 Oncogene as Molecular Target in Uterine Serous Carcinoma and Uterine Carcinosarcoma.
Journal: Cancers
Published: July 01, 2023
Monitoring Treatment Response, Early Recurrence, and Survival in Uterine Serous Carcinoma and Carcinosarcoma Patients Using Personalized Circulating Tumor DNA Biomarkers.
Journal: International journal of molecular sciences
Published: May 03, 2023
Last Updated: 09/26/2026